A new trading day began on Tuesday, with Humana Inc (NYSE: HUM) stock price down -6.03% from the previous day of trading, before settling in for the closing price of $274.74. HUM’s price has ranged from $206.87 to $315.35 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -13.05% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 5.24%. With a float of $120.01 million, this company’s outstanding shares have now reached $120.27 million.
Humana Inc (HUM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Healthcare Plans Industry. The insider ownership of Humana Inc is 0.22%, while institutional ownership is 96.80%. The most recent insider transaction that took place on May 14 ’25, was worth 1,496,984. In this transaction President & CEO of this company bought 6,530 shares at a rate of $229.25, taking the stock ownership to the 30,474 shares. Before that another transaction happened on Apr 08 ’25, when Company’s Former Chief Financial Officer proposed sale 10,959 for $249.31, making the entire transaction worth $2,732,134.
Humana Inc (HUM) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.16 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 10.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.44% during the next five years compared to -13.05% drop over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Here are Humana Inc’s current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 20.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 10.67, a number that is poised to hit -4.02 in the next quarter and is forecasted to reach 12.39 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.82 million. That was better than the volume of 1.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 73.30%.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 39.06%, which indicates a significant decrease from 57.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 9.24 in the past 14 days, which was lower than the 9.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $262.19, while its 200-day Moving Average is $258.68. However, in the short run, Humana Inc’s stock first resistance to watch stands at $266.99. Second resistance stands at $275.82. The third major resistance level sits at $281.29. If the price goes on to break the first support level at $252.69, it is likely to go to the next support level at $247.22. The third support level lies at $238.39 if the price breaches the second support level.
Humana Inc (NYSE: HUM) Key Stats
With a market capitalization of 31.05 billion, the company has a total of 120,273K Shares Outstanding. Currently, annual sales are 117,761 M while annual income is 1,207 M. The company’s previous quarter sales were 32,649 M while its latest quarter income was 195,000 K.
